Baxter and Amphenol

Two of our Buy List stocks reported earnings this morning, and they were both pretty good.
Amphenol (APH) earned 43 cents a share down from 54 cents a share last year. They had a two-cent benefit, so the 41 cents was a penny better than expectations (though FactSet said consensus was 39 cents. Hmm. No consensus on consensus).
Revenue fell 14.4% to $660 million which was a bit better than the $654.8 million consensus. The company sees Q2 EPS coming in between 41 and 43 cents, and revenues between $660 million and $675 million. The stock seems a bit pricey right now, but terribly overpriced.
The other earnings report came from Baxter International (BAX). First-quarter EPS came in at 83 cents which is a nice improvement from 67 cents a year ago. Sales actually fell 1.8% but if you discount currency moves, they were really up about 6%.
For the year, BAX sees EPS coming in between $3.72 and $3.78. They raised the low end by two cents. For Q2, they see earnings in a range of 93 cents to 95 cents a share.
Both stocks are doing well this morning.

Posted by on April 16th, 2009 at 11:21 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.